{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:04:50Z","timestamp":1784016290246,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-14-00088"],"award-info":[{"award-number":["24-14-00088"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nano.2026.102964","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T05:28:54Z","timestamp":1780205334000},"page":"102964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multifunctional theranostic nanoplatform based on HER2-specific liposomes loaded with IR783 for simultaneous PTT\/PDT therapy and optical bioimaging"],"prefix":"10.1016","volume":"75","author":[{"given":"E.I.","family":"Shramova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Yu.","family":"Frolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"Serova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.D.","family":"Serova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Yu.","family":"Baranov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Deyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Proshkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102964_bb0005","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/adma.201404308","article-title":"An imagable and photothermal \u201cAbraxane-like\u201d nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors","volume":"27","author":"Chen","year":"2015","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102964_bb0010","doi-asserted-by":"crossref","first-page":"19438","DOI":"10.1039\/C5NR04587H","article-title":"Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model","volume":"7","author":"Zhou","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2026.102964_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2023.11.036","article-title":"Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases","volume":"365","author":"Komedchikova","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102964_bb0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2015.01.029","article-title":"InCVAX\u2014a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity","volume":"359","author":"Zhou","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2026.102964_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2026.115720","article-title":"Reduction\/pH dual responsive micelle delivery system for cancer chemo\/photothermal\/photodynamic therapy","volume":"265","author":"Fang","year":"2026","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2026.102964_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145131","article-title":"Preparation and antitumor of hyaluronic acid-human serum albumin-indocyanine green-paclitaxel nanoparticles","volume":"318","author":"Li","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2026.102964_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114076","article-title":"Pt(IV) complexes loaded hollow copper sulfide nanoparticles for tumor chemo\/photothermal\/photodynamic therapy","volume":"242","author":"Chen","year":"2024","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2026.102964_bb0040","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and photothermal therapies: synergy opportunities for nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102964_bb0045","doi-asserted-by":"crossref","first-page":"27421","DOI":"10.1038\/srep27421","article-title":"Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT\/PTT agent for cancer therapy","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102964_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jfb15120363","article-title":"Photodynamic therapy using IR-783 liposomes for advanced tongue and breast cancers in humans","volume":"15","author":"Komura","year":"2024","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.nano.2026.102964_bb0055","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1134\/S1068162025601879","article-title":"Targeted nanoliposomes loaded with IR780 dye as a multifunctional nanoplatform for photothermal and photodynamic cancer therapy","volume":"51","author":"Proshkina","year":"2025","journal-title":"Russia J Bioorg Chem"},{"key":"10.1016\/j.nano.2026.102964_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179118","article-title":"Targeted delivery of drugs and genes using polymer nanocarriers for cancer therapy","volume":"22","author":"Xia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102964_bb0065","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1021\/acs.chemrev.5b00589","article-title":"targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies","volume":"116","author":"Ulbrich","year":"2016","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2026.102964_bb0070","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2026.102964_bb0075","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.nano.2026.102964_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.nano.2026.102964_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194806","article-title":"Novel small multilamellar liposomes containing large quantities of peptide nucleic acid selectively kill breast cancer cells","volume":"14","author":"Proshkina","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nano.2026.102964_bb0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejpb.2023.11.008","article-title":"HER2-specific liposomes loaded with proteinaceous BRET pair as a promising tool for targeted self-excited photodynamic therapy","volume":"193","author":"Shramova","year":"2023","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2026.102964_bb0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.32607\/actanaturae.27722","article-title":"Targeted nanoliposomes for the delivery of boronophenylalanine into HER2-positive cells","volume":"17","author":"Proshkina","year":"2025","journal-title":"Acta Naturae"},{"key":"10.1016\/j.nano.2026.102964_bb0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.32607\/actanaturae.27425","article-title":"A vector nanoplatform for the bioimaging of deep-seated tumors","volume":"16","author":"Shramova","year":"2024","journal-title":"Acta Nat"},{"key":"10.1016\/j.nano.2026.102964_bb0105","article-title":"Liposomes for tumor targeted therapy: a review","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102964_bb0110","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1158\/1078-0432.CCR-13-1212","article-title":"First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer","volume":"19","author":"Blumenthal","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2026.102964_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2026.102964_bb0120","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.102964_bb0125","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17425247.2015.993313","article-title":"Albumin and its application in drug delivery","volume":"12","author":"Sleep","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2026.102964_bb0130","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1016\/j.biomaterials.2013.07.102","article-title":"Preformed albumin corona, a protective coating for nanoparticles based drug delivery system","volume":"34","author":"Peng","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2026.102964_bb0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jconrel.2023.02.004","article-title":"Regulation of protein corona on liposomes using albumin-binding peptide for targeted tumor therapy","volume":"355","author":"Li","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102964_bb0140","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1007\/s00259-024-06840-5","article-title":"Evaluation of a novel (177)Lu-labelled therapeutic affibody molecule with a deimmunized ABD domain and improved biodistribution profile","volume":"51","author":"Liu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nano.2026.102964_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150747","article-title":"A novel HER2-specific sensor based on DARPin_9-29 and albumin binding domain for real-time fluorescence-guided tumor detection in animal model of cancer","volume":"734","author":"Shramova","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2026.102964_bb0150","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jmb.2008.07.085","article-title":"Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display","volume":"382","author":"Steiner","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nano.2026.102964_bb0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.nano.2026.102964_bb0160","article-title":"Structure-inherent tumor-targeted IR-783 for near-infrared fluorescence-guided photothermal therapy","volume":"25","author":"Park","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102964_bb0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejpb.2018.06.026","article-title":"Selective staining and eradication of cancer cells by protein-carrying DARPin-functionalized liposomes","volume":"130","author":"Deyev","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2026.102964_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14050994","article-title":"Laser synthesized core-satellite Fe-Au nanoparticles for multimodal in vivo imaging and in vitro photothermal therapy","volume":"14","author":"Griaznova","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102964_bb0175","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1134\/S1607672925601155","article-title":"A syngenic mouse model of breast cancer expressing human ERBB2 and NanoLuc luciferase genes","volume":"524","author":"Shramova","year":"2025","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.nano.2026.102964_bb0180","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/mt.2013.16","article-title":"DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety","volume":"21","author":"Friedrich","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2026.102964_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.nano.2026.102964_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214621","article-title":"Design of 3D spheroid models for drug-response studies of HER2-targeted radiopharmaceuticals","volume":"180","author":"Zelepukin","year":"2026","journal-title":"Biomater Adv"},{"key":"10.1016\/j.nano.2026.102964_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.mie.2016.05.002","article-title":"Cell-binding assays for determining the affinity of protein-protein interactions: technologies and considerations","volume":"580","author":"Hunter","year":"2016","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nano.2026.102964_bb0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nprot.2015.024","article-title":"Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy","volume":"10","author":"Yang","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nano.2026.102964_bb0205","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00249-021-01502-y","article-title":"Evaluation of protein secondary structure from FTIR spectra improved after partial deuteration","volume":"50","author":"De Meutter","year":"2021","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.nano.2026.102964_bb0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0891-5849(87)80033-3","article-title":"Spin trapping: ESR parameters of spin adducts","volume":"3","author":"Buettner","year":"1987","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nano.2026.102964_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(80)90323-9","article-title":"Spin trapping of superoxide and hydroxyl radical: practical aspects","volume":"200","author":"Finkelstein","year":"1980","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.nano.2026.102964_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153690","article-title":"Liposomal IR-780 as a highly stable nanotheranostic agent for improved photothermal\/photodynamic therapy of brain tumors by convection-enhanced delivery","volume":"13","author":"Lu","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:25:14Z","timestamp":1784013914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":44,"alternative-id":["S1549963426000651"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102964","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifunctional theranostic nanoplatform based on HER2-specific liposomes loaded with IR783 for simultaneous PTT\/PDT therapy and optical bioimaging","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102964"}}